🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Very proud that our CEO Maria Bech is nominated for CEO of the Year at tonight’s LSX Leaders European #Lifestarsawards. Good luck to all the nominees!

Our CEO Maria Bech is to present at this year’s SALSS Science4Peace summit in Stockholm today, exploring the connection between science and peace. #SALSS #Science4Peace #lifesciences tinyurl.com/34vfj4bz

We’re pleased to welcome Dr Kate Hanrott to the EpiEndo team as our new Director of Clinical Operations and Sciences! With more than 16 years industry experience, her expertise will help drive our clinical development programmes: bit.ly/3YyXpPN #COPD #DrugDevelopment

Online meetings are functional, but nothing beats meeting in-person!  Excited to finally connect with Alveolix, our partner in the EPIcoliX project addressing ulcerative colitis with novel #drugs and methods after nearly 2 years.   #InPerson #Collaboration

Mark your calendars and join us at #BIOEuropeSpring to learn about our unique approach to treating #inflammatorydisorders. Don't miss our CEO, Maria Bech, at the company presentations on Monday 20 March in Basel, Switzerland. Catch us at the Exhibit Hall Stage at 15:15.

#BIOEuropeSpring is in full swing! Our CEO Maria Bech & CFO Stefan Petursson are in attendance, presenting our unique approach to treating #inflammatorydisorders. Don't miss Maria's presentation on the Exhibit Hall Stage at 15:15. If you're in Basel, Switzerland, come say hello!

The BIO International Convention is just a few weeks away, and our CEO, Maria Bech, and CFO, Stefán Pétursson, will be joining thousands of #biotech and pharma leaders at #BIO2023 in Boston, June 5-8. To connect, get in touch through the partnering system: bit.ly/3nZUJxn

CEO, Maria Bech, and CFO, Stefán Pétursson will be at the highly anticipated #BIO2023 International Convention from June 5-8 in Boston. Let's catch up, share insights & have fun! If you're attending, make sure to connect via the partnering system: bit.ly/3nZUJxn

The BIO International Convention is underway, and we're thrilled to be here! Join CEO Maria Bech and CFO Stefán Pétursson as they discuss our transformative treatments for #inflammatory disorders. #Connect with us via the partnering system: bit.ly/3nZUJxn #BIO2023

Proud of our team & Scientific Advisory Board! We co-authored a chapter in a major medical textbook . Titled "Prospects for Macrolide Therapy of Asthma and #COPD," it's in the latest "Pulmonary Pharmacology," edited by W.S. Fred Wong. Read more here: bit.ly/3YJaE1d

The ERS International Congress 2023 is just around the corner, starting on 9th September in #Milan. Come and meet us there and see the posters showcasing the recent #research into lead asset #EP395 and its mechanism of action. Look forward to seeing you at #ERSConference 2023!

Day 3 at the ERS International Congress 2023 in Milan! We're already deep into the event, but there's still time to connect with us and explore our research on #EP395 and its unique mechanism of action. Come say hello, chat with our team, and discover the innovative work we do.

This week we announced a key milestone in our mission to treat chronic airway diseases, completing a proof of pharmacology study for lead asset EP395 - showing a positive effect on inflammation and epithelial function in LPS-challenged healthy volunteers: shorturl.at/uJM26

We've initiated our new IND-opening study, a drug-drug interaction study for EP395 in healthy volunteers. With results expected in Q1 2024, the data from this study will help ensure as wide a range of patients as possible can be included in future trials #COPD #IND #clinicaltrial

CEO Maria Bech and CFO Stefán Pétursson will be at LSX Leaders Investival Showcase 2023 on Monday 13 November meeting industry and investors. If you'd like to connect with us there, get in touch! lsxleaders.com/investival-sho… #LSXinvestival #partnering #investors

November is World COPD Awareness Month. COPD is the 3rd largest cause of death globally but is hugely neglected, with no current cure. We're supporting this important cause and working to bring a potential treatment to COPD patients. #COPDawarenessmonth #copdawareness #COPD

Today, we've been wearing orange for World COPD Day and to raise awareness of this chronic and neglected disease. Along with our investigators, partners and KOLS, our team is working towards better treatments for COPD patients #worldCOPDday #copdawarenessmonth

Some more snaps of our team embracing orange for World COPD Day yesterday! Proud of our staff helping raise awareness of this neglected disease area. #worldcopdday #copd #copdawarenessmonth